Rational Therapeutics, Inc Company Profile

09:03 EDT 23rd March 2018 | BioPortfolio

Who are we?
Rational Therapeutics, Inc. (RTI) is a free-standing research laboratory located in Long Beach, CA. Founded in 1993 by Dr. Robert Nagourney, a prominent hematologist/oncologist, Rational Therapeutics pioneers intelligent cancer therapies that are scientifically tailored for each individual patient.

What do we do?

Rational Therapeutics develops and provides cancer therapy recommendations, which have been designed specifically for each patient. Following the collection of living cancer cells obtained at the time of biopsy or surgery, Rational Therapeutics performs an EVA™ (Ex-Vivo Assay) on your tumor sample to measure drug activity (sensitivity and resistance). This will determine exactly which drug(s) will be most effective for YOU. We then make our treatment recommendation. The treatment program developed through this approach is known as "assay-directed therapy."


750 East 29th St.
Long Beach
United States of America


Phone: (562) 989-6455
Fax: (562) 989-8160

News Articles [756 Associated News Articles listed on BioPortfolio]

Rational addiction and Naloxone

Suppose for a moment that addicts are rational and that we’re really in a Becker-Murphy world. What happens in that world if a new technology makes it safer to consume an addictive product? If y...

Why do we believe in gods? Religious belief 'not linked to intuition or rational thinking'

Religious beliefs are not linked to intuition or rational thinking, according to a new study. Previous studies have suggested people who hold strong religious beliefs are more intuitive and less analy...

Rational design of proteins that exchange on functional timescales

Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations

L‐cysteine production in Escherichia colibased on rational metabolic engineering and modular strategy

L‐cysteine is an amino acid with important physiological functions and has a wide range of applications in medicine, food, animal feed and cosmetics industry. In this study, the L‐cysteine synthes...

Rational design of an efficient halotolerant enzymatic system for in vitro one‐pot synthesis of cytidine diphosphate choline

Salt accumulation often impedes cytidine diphosphate choline (CDP‐choline)in vitro biosynthetic process. In this work a halotolerant in vitroenzymatic system was developed to solve this problem. It ...

Global Veterinary Therapeutics Market to Mark CAGR of 6.0% Over Next 10 Years - announces publication of its recently generated research report titled, "GlobalVeterinary Therapeutics MarketBy Type (Therapeutics Drugs, Therapeutics Vaccines, Feed Additives The...

Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48

PubMed Articles [536 Associated PubMed Articles listed on BioPortfolio]

Does knowing that a suicide was "rational" influence grief?

Counseling professionals and graduate students (N = 117) recruited online read a randomly assigned one-paragraph vignette about either a non-rational or rational suicide involving an imaginary lov...

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Analysis of inappropriate medication use and drug interactions in older people in South Korea

Medication use in older people has been increasing as the incidence of chronic diseases increases worldwide. The objective of this study was to assess potentially inappropriate medications (PIMs) and ...

Rational use of medicines, pharmaceuticalization and uses of methylphenidate.

The rational use of medicines (URM) is considered one of the key elements recommended by the World Health Organization (WHO) for pharmaceutical policies. The excessive increase in the use of medicines...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Clinical Trials [267 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1249 Associated Companies listed on BioPortfolio]

Rational Therapeutics, Inc

Who are we?Rational Therapeutics, Inc. (RTI) is a free-standing research laboratory located in Long Beach, CA. Founded in 1993 by Dr. Robert Nagourney, a prominent hematologist/oncologist, Rational Th...

Paradigm Therapeutics Incorporated

Paradigm Therapeutics is an emerging drug discovery company focussed on the pharmaceutical exploitation of the human genome. The race to define biological function of the thousands of uncharacterised ...

GlycoMimetics, Inc. (GMI)

GlycoMimetics is a privately held biotechnology company that capitalizes on advances in the field of glycobiology. The company uses rational design of small molecule drugs that mi...

GlycoMimetics, Inc.

GlycoMimetics is a privately held biotechnology company that capitalizes on advances in the field of glycobiology. The company uses rational design of small molecule drugs that mi...

Numab Therapeutics AG

Founded in 2011, Numab develops a proprietary pipeline of multi-specific biotherapeutics in immuno-oncology and immunology, and has a number of discovery partnerships with pharmac...

More Information about "Rational Therapeutics, Inc" on BioPortfolio

We have published hundreds of Rational Therapeutics, Inc news stories on BioPortfolio along with dozens of Rational Therapeutics, Inc Clinical Trials and PubMed Articles about Rational Therapeutics, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rational Therapeutics, Inc Companies in our database. You can also find out about relevant Rational Therapeutics, Inc Drugs and Medications on this site too.

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record